🙏🏾Honored to co-moderate🎙️'#SGLT2Inhibitors: Are #Gliflozins a Game Changer for Improving #PostTransplant Outcomes?' w/ #DrJohnGill
• Experts #ArthusMatas @AdnanSharif1979 ➕@DeirdreSawinski consider: Do general population benefits of translate to #kidneytransplant recipients❓
0
0
0
0